(4-(4-甲氧基苯基)四氢-2H-吡喃-4-基)甲胺 | 440087-51-4

• 物质功能分类: 生物化工 - 生化试剂 - 胺、酸和盐
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: (4-(4-甲氧基苯基)四氢-2H-吡喃-4-基)甲胺
• 英文名称: 1-[4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]-methylamine
• 英文别名: (4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl)methanamine；[4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methanamine；[4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methylamine；[4-(4-methoxyphenyl)tetrahydropyran-4-yl]methylamine；{[4-(4-methoxyphenyl)-tetrahydro-2H-pyran-4-yl]methyl}amine；[4-(4-Methoxyphenyl)oxan-4-yl]methanamine
• CAS: 440087-51-4
• 化学式: C₁₃H₁₉NO₂
• mdl: MFCD03447533
• 分子量: 221.299
• InChiKey: CICNVPXSEFWGBP-UHFFFAOYSA-N

物化性质

• 沸点：
  344.6±27.0 °C(Predicted)
• 密度：
  1.059±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2932999099
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  (4-(4-甲氧基苯基)四氢-2H-吡喃-4-基)甲胺 在 三甲基铝 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 18.0h， 生成 5-methyl-[1,3,4]oxadiazole-2-carboxylic acid (3-chloro-4-{[4-(4-methoxyphenyl)tetrahydropyran-4-ylmethyl]carbamoyl}phenyl)amide
  参考文献：
  名称：

  [EN] WNT PATHWAY INHIBITORS
  [FR] INHIBITEURS DE LA VOIE WNT

  摘要：

  公开号：

  WO2013093508A3
• 作为产物：
  描述：

  对甲氧基苯乙腈 在 lithium aluminium tetrahydride 、 sodium hydride 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 生成 (4-(4-甲氧基苯基)四氢-2H-吡喃-4-基)甲胺
  参考文献：
  名称：

  New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold

  摘要：

  Tetrahydropyran derivative 1 was discovered in a high-throughput screening campaign to find new inhibitors of mycobacterial InhA. Following initial in-vitro profiling, a structure-activity relationship study was initiated and a focused library of analogs was synthesized and evaluated. This yielded compound 42 with improved antimycobacterial activity and low cytotoxicity. Additionally, the crystal structure of InhA in complex with inhibitor 1 was resolved, to reveal the binding mode and provide hints for further optimization. (C) 2016 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2016.02.008

文献信息

• 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
  申请人：Warner-Lambert Company LLC

  公开号：EP1593679A1

  公开（公告）日：2005-11-09

  The invention relates to 3- or 4-monosubstituted phenol derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol derivatives are H3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

  这项发明涉及3-或4-单取代酚衍生物，以及用于制备、制备中间体、含有和使用这些衍生物的过程。所述的3-或4-单取代酚衍生物是H3配体，在许多疾病、紊乱和状况中非常有用，特别是炎症性、过敏性和呼吸系统疾病、紊乱和状况。
• Synthesis of Dicarboxylic Acid Amides and Diamides on the Basis of [4-(4-Methoxyphenyl)tetrahydro-2H-pyran-4-yl]methanamine
  作者：A. A. Aghekyan、G. G. Mkryan、R. E. Muradyan、A. E. Tumajyan

  DOI：10.1134/s1070428018060106

  日期：2018.6

  ethyl N-[4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methyl}oxamate prepared from [4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methanamine and diethyl oxalate afforded the corresponding N,N'-disubstituted oxamides. N-Aryloxamides were synthesized by the reaction of [4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methanamine with ethyl N-aryloxamates. The condensation of N-[4-(4-methoxyphenyl)tetrah

  各种非芳族胺的用乙酸乙酯缩合ñ - [4-（4-甲氧基苯基）四氢-2 ħ -吡喃-4-基]甲基}从制备草氨酸乙酯[4-（4-甲氧基苯基）四氢-2 ħ -pyran- 4-基]甲胺和草酸二乙酯得到相应的N，N′-二取代的草酰胺。Ñ -Aryloxamides由[4-（4-甲氧基苯基）四氢-2的反应合成ħ -2H-吡喃-4-基]甲胺用乙酸乙酯Ñ -aryloxamates。的缩合ñ - [4-（4-甲氧基苯基）四氢-2 ħ -吡喃-4-基]甲基}琥珀酰胺酸与伯胺，得到Ñ，Ñ'-二取代的神经酰胺。
• 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands
  申请人：Bernardelli Patrick

  公开号：US20050267095A1

  公开（公告）日：2005-12-01

  The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol and thiophenol derivatives are H 3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

  本发明涉及公式(I)的3-或4-单取代苯酚和硫代苯酚衍生物，以及用于制备这些衍生物的中间体、含有这些衍生物的组合物和这些衍生物的用途的过程。所述的3-或4-单取代苯酚和硫代苯酚衍生物是H3配体，在许多疾病、失调和病况中特别有用，特别是在炎性、过敏和呼吸系统疾病、失调和病况中。
• Heterocyclo inhibitors of potassium channel function
  申请人：Lloyd John

  公开号：US20060014792A1

  公开（公告）日：2006-01-19

  Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the K v 1 subfamily of voltage gated K + channels, especially inhibitors K v 1.5 which has been linked to the ultra-rapidly activating delayed rectifier K + current I Kur ), methods of using such compounds in the prevention and treatment of arrhythmia and I Kur -associated conditions, and pharmaceutical compositions containing such compounds.

  新型杂环化合物可用作钾通道功能的抑制剂（尤其是Kv1电压门控K+通道的抑制剂，特别是抑制Kv1.5，该通道已与超快速激活延迟整流K+电流IKur相关联），使用这种化合物预防和治疗心律失常和IKur相关病症的方法，以及含有这种化合物的制药组合物。
• HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION
  申请人：Lloyd John

  公开号：US20090312307A1

  公开（公告）日：2009-12-17

  Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the K v 1 subfamily of voltage gated K + channels, especially inhibitors K v 1.5 which has been linked to the ultra-rapidly activating delayed rectifier K + current I Kur ), methods of using such compounds in the prevention and treatment of arrhythmia and I Kur -associated conditions, and pharmaceutical compositions containing such compounds.

  新型杂环化合物，可作为钾通道功能抑制剂使用（特别是Kv1亚家族电压门控K+通道的抑制剂，特别是与超快速激活延迟整流K+电流IKur相关的Kv1.5抑制剂），使用这种化合物预防和治疗心律失常和IKur相关疾病的方法，以及含有这种化合物的制药组合物。